Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2024
2024
Rethinking and remaking all of healthcare at scale. Curious? Drop me a line...
2021
2024
2021 - 2023
HC9 is an early-stage venture capital firm purpose-built to provide industry-specific expertise to emerging healthcare software and services companies. HC9's unparalleled, deeply engaged investor community of leading executives, entrepreneurs and investors collectively has thousands of years of experience in all facets of healthcare. We leverage the power of that experience to support the founders that are shaping the future of healthcare.
2019
Created and teach Masters-level course on venture investing in healthcare
2019 - 2021
2019 - 2021
Responsible for designing, building and leading the innovation program for CCA, a Massachusetts-based dual-eligible payor/provider. Identify opportunities for leveraging innovation to drive organizational improvement and change through a periodic comprehensive needs assessment. Engage with start-ups to identify potential fit and align with investment opportunities. Participate in overall organizational planning and management for CCA as part of our senior leadership team.
2019 - 2021
2019 - 2021
Led venture investment for Commonwealth Care Alliance's (CCA) venture investment subsidiary. Responsible for designing and building processes, policies, infrastructure and team for Winter Street. Align investment activity with innovation priorities for CCA. Serve as an advocate for venture investment with the executive team and Board of Directors.
2020 - 2021
2020 - 2021
Stepped in to lead Winter Street Ventures portfolio company LifePod after we took a majority stake in the company in the face of the COVID-19 pandemic. LifePod is a proactive voice-based remote patient monitoring and engagement solution that enables payor and providers to identify and manage social, behavioral and medical needs.
2010 - 2019
2015 - 2019
Founded and led group responsible for venture investment, strategic partnerships and technology transfer for $8.5 billion academic medical center.
2012 - 2019
Led policy and research group responsible for advocating for the role of academic medical centers in identifying solutions to the challenges facing the American healthcare system.
2010 - 2015
As a member of the Strategy team, led a wide range of projects, from developing NYP’s Accountable Care Organization, to its telehealth program, to its genomic medicine program.
2015 - 2019
2015 - 2019
• Director, Weill Cornell EMBA/MS Capstone Program • Creator and teacher of course on Leading Healthcare Transformation • Guest lecturer on health policy and healthcare leadership for residents and medical students • Recipient of Weill Cornell Excellence in Teaching Award
2014 - 2018
2014 - 2018
Advisor to Vital Score (acquired by Phreesia)
2006 - 2009
2006 - 2009
Founder and operating partner of an e-commerce-based provider of home and durable medical equipment.